PRAX
Praxis Precision Medicines Inc

1,008
Loading...
Loading...
News
all
press releases
Deutsche Bank initiates coverage of biopharma stocks, sees 'modest recovery'
Investing.com -- Deutsche Bank initiated coverage on 11 U.S. biopharma stocks in a note Tuesday, assigning Buy ratings to eight companies and Hold ratings to three. 
investing.com·7mo ago
News Placeholder
More News
News Placeholder
GeneDx to Expand Access to Exome Testing for Pediatric Epilepsy Patients with New Partners
GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Biogen (Nasdaq: BIIB), Praxis Precision Medicines (Nasdaq: PRAX) and Stoke Therapeutics...
Business Wire·9mo ago
News Placeholder
Praxis Precision Medicines Touts Encouraging Data For Mid-Stage Epilepsy Drug
Praxis Precision Medicines reports positive Phase 2 EMBOLD study results for relutrigine in treating SCN2A and SCN8A developmental and epileptic encephalopathy, showing significant seizure reduction...
Benzinga·1y ago
News Placeholder
Praxis Precision Medicines' Promising EMBOLD Study Outcomes
The latest update is out from Praxis Precision Medicines (PRAX). Praxis Precision Medicines, Inc. has reported promising results from its EMBOLD st...
TipRanks Financial Blog·1y ago
News Placeholder
These Analysts Increase Their Forecasts On Praxis Precision Medicines After Q2 Results
Latest Ratings for PRAX DateFirmActionFromTo Dec 2021HC Wainwright & Co.Initiates Coverage OnBuy Aug 2021B of A SecuritiesInitiates Coverage OnBuy Apr 2021William BlairInitiates Coverage...
Benzinga·1y ago
News Placeholder
Analysts' Top Healthcare Picks: Immunocore Holdings (IMCR), Praxis Precision Medicines (PRAX)
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Immunocore Holdings (IMCR Research Report) and Praxis Precision Medicines...
TipRanks Financial Blog·1y ago
News Placeholder
Praxis Precision Medicines (NASDAQ:PRAX) Shares Gap Up to $50.74
Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Get Free Report) shares gapped up prior to trading on Friday . The stock had previously closed at $50.74, but opened at $52.12. Praxis Precision...
Ticker Report·1y ago
News Placeholder
Praxis Precision Medicines (NASDAQ:PRAX) Stock Price Down 6.1%
Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Get Free Report) traded down 6.1% on Wednesday . The company traded as low as $51.82 and last traded at $52.18. 81,782 shares changed hands...
Ticker Report·1y ago
News Placeholder
Praxis Precision Medicines to Participate in Upcoming April Conferences
BOSTON, April 05, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies...
Globe Newswire·1y ago
News Placeholder
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, April 02, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies...
Globe Newswire·1y ago

Latest PRAX News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.